BUFFALO, N.Y. — Purity Scientific LLC, a parent company of GenTech Scientific which is a leading provider and servicer of refurbished scientific instruments, announced that it has acquired Conquer Scientific. The acquisition combined two industry leaders, allowing us to be number one in the world with a robust service network, unmatched resources, and an unparalleled inventory of […]
Polyplus today announces the acquisition of E-Zyvec with a focus on expanding process economics optimization efforts for cell and gene therapy developers and manufacturers. Strasbourg, France – Polyplus, a leading provider of upstream process solutions for advanced biologic and cell and gene therapy production from research to commercial grade, today announces the acquisition of e-Zyvec, […]
CHELMSFORD, Mass. — Azenta, Inc. (Nasdaq: AZTA) today announced that it has completed the previously announced sale of the company’s Semiconductor Solutions Group business (or “automation business”) to Thomas H. Lee Partners (“THL”) for $3.0 billion in cash, subject to adjustments for working capital and other items. Proceeds from the sale, net of taxes, fees and adjustments, are […]
Informatics Capabilities Help Expand BD Data Analytics Capabilities and Understanding of Cancer and Other Chronic Diseases FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of Cytognos, a privately held company headquartered in Salamanca, Spain, specializing in flow cytometry solutions […]
News Summary: Waters has acquired technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS). CDMS overcomes limitations of conventional mass spectrometry in characterizing complex large molecules in cell and gene therapies. CDMS technology will be further developed to extend capabilities of Waters’ mass spectrometry portfolio for […]
MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s TriLink mRNA technologies Increases capabilities serving the high-growth cell and gene therapy market SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has acquired MyChem, LLC for $240 million in […]
New York, New York – Global investment firm Carlyle (NASDAQ: CG) today announced that funds managed by Carlyle have sold Thomas Scientific, a leading distributor and sourcing partner to the life sciences industry, to Broad Sky Partners. Financial terms of the transaction were not disclosed. Founded in 1900, Thomas Scientific provides a comprehensive offering of supplies, […]
Led by Veteran Private Equity Executives, Firm Makes Sector-Focused, Thematic Investments in Leading Middle Market Companies NEW YORK — Broad Sky Partners today announced a strategic investment from Capital Constellation, as well as its acquisition of Thomas Scientific, marking the team’s first transaction. As a private equity firm that partners with leading middle market business […]
Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has purchased Amaryllis Nucleics, a Bay Area-based start-up company focused on proprietary RNA Sequencing methods. Amaryllis Nucleics provides Active Motif with a streamlined, low-cost library preparation method to perform high-efficiency RNA sequencing using their intellectual property […]
Acquisition combines Aldevron’s leadership in GMP manufacturing with Nature Tech’s portfolio of proprietary technologies. Aldevron has acquired Nature Technology Corporation (NTC), a developer of innovative and proprietary plasmid constructs and manufacturing solutions that are used in the field of cell and gene therapy. NTC’s nucleic acid-based technologies include NanoplasmidTM, a proprietary vector construct that improves […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
